Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University of Cambridge has shown.
Feb 12, 2025
0
278
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline immune soldiers—respond to infections like COVID-19. Their research suggests that the disease fighting ...
Feb 10, 2025
0
54
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...
Feb 5, 2025
0
195
Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine vial.
Jan 30, 2025
0
85
Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a study published ...
Jan 28, 2025
0
80
People who get their news from an ideologically diverse array of sources are more likely to get vaccinated, regardless of their political affiliation, new University of Colorado Boulder research shows.
Jan 27, 2025
2
3
Engineering and medical researchers at Penn have developed a framework that can determine the best and most computationally optimized distribution strategy for COVID-19 vaccinations in any given community.
Jan 22, 2025
0
23
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by researchers at Penn State, could eliminate the need for refrigeration for hundreds of life-saving medicines ...
Jan 16, 2025
0
50
A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases. By providing insights into the cellular ...
Jan 15, 2025
0
53
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.
Jan 15, 2025
0
103
